Pre Exposure Prophylaxis News and Research

RSS

New simulation approach predicts efficacy of HIV-prophylaxis medications

A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal and Max von Kleist of Freie Universität Berlin and colleagues, could help streamline development of new PrEP treatments.

18 Jun 2018

Multiple barriers may stop high-risk individuals from accessing HIV drug

Multiple barriers may stop high-risk individuals from accessing an HIV drug that can reduce the subsequent risk of infection, according to a new University of Michigan study.

12 Jun 2018

PrEP uptake on the rise and condom use declines in gay men

Some parts of Australia show an increase in uptake of pills that can prevent contracting HIV but also a sharp drop in condom use among men having sex with men. This was found in a major study and is cause for concern.

7 Jun 2018

Study examines social perceptions of HIV-prevention drug among gay and bisexual men

A new study led by a UTSA researcher examines the social perceptions of Pre-Exposure Prophylaxis (PrEP), a medication to prevent HIV, among gay and bisexual men in Texas.

9 May 2018

PrEP campaign aims to block HIV infection and save lives in D.C.

A big part of Washington, D.C.’s plan to get its HIV rate down is to get more uninfected people on PrEP, a two-medicine combination pill that’s sold under the brand name Truvada.

13 Apr 2018

Grindr may be sharing user HIV status without consent

Gay dating app Grindr has released a new feature recently that allows its users to opt for HIV testing reminders. A new data analysis from SINTEF, a Norwegian research firm, has revealed that Grindr could be sharing this sensitive information regarding the users’ HIV status with two other companies.

2 Apr 2018

Use of HIV-prevention drug grows, but lags among non-whites

Eric Russell, 24, recently joined a health support group for young Latino and black gay men, where he learned about the HIV-prevention pill known as PrEP. He resisted the medication at first, convinced he didn't need it and fearful that taking it would stigmatize him.

15 Mar 2018

UNC study finds HIV risk patterns among people who inject drugs in Vietnam

People who inject drugs (PWID) in Vietnam are disproportionately affected by HIV. While HIV prevalence among the general population aged 15-49 is 0.4 percent, the prevalence of HIV among people who inject drugs is a staggering 11 percent, according to UNAIDS.

6 Feb 2018

Scientists find increased risk of HIV outbreaks in Ukraine due to war-related migration

Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

16 Jan 2018

U.S.-funded global effort appears to reduce incidence of new HIV infections

A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine.

30 Nov 2017

Over half of reported HIV diagnoses in Europe happen in late stage of infection

The WHO European Region is the only Region worldwide where the number of new HIV infections is rising. With more than 160 000 people newly diagnosed with HIV across the Region, including more than 29 000 new cases from the European Union and European Economic Area, this trend continued in 2016.

29 Nov 2017

New HIV prevention guidelines from Canada released

New guidelines for Canada have been published in the Canadian Medical Association Journal online this week that outline the use of new anti-HIV medications among high risk populations who are at risk of contracting HIV from getting the dreaded infection. These new guidelines aim to provide the clinicians with resources and support he added.

27 Nov 2017

New Canadian guideline outlines cost-effective strategies to prevent HIV in high-risk population

A new Canadian guideline outlines how new biomedical strategies to prevent HIV infection can best be used in high-risk populations both before and after exposure to the virus.

27 Nov 2017

Gonorrhea and syphilis cases rise in Australia

The Annual Surveillance Report on HIV, viral hepatitis and sexually transmissible infections (STIs) in Australia was released and it revealed that there is a rise in diagnosis of gonorrhea and syphilis but the number of people being affected by HIV has plateaued. In addition tens of thousands of people have been cured of Hepatitis C. The report comes from the Kirby Institute at UNSW Sydney.

5 Nov 2017

Study: PrEP program for men who have sex with men could lead to long-term cost savings

Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, and could help to prevent up to one in four cases of HIV, according to a study published in The Lancet Infectious Diseases journal.

19 Oct 2017

HIV pre-exposure prophylaxis (PrEP) could be cost saving for NHS in long run

For men who have sex with men in the UK, a programme that involved providing pre-exposure prophylaxis (PrEP) treatment for HIV could be cost effective and cost saving finds a new study. The economic evaluation was made by a team led by Valentina Cambiano, of University College London and published in the latest issue of Lancet Infectious Diseases.

18 Oct 2017

HIV prevention drug to be trialed by Britain's NHS

After a High Court case, an HIV prevention drug is soon to be available on the NHS. NHS England has issued a statement saying that pre-exposure prophylaxis (PrEP) treatment for HIV shall be available to an initial 10,000 people for a trial period of three years.

3 Aug 2017

UNC scientists receive NIH grant to develop new implantable drug delivery system for HIV prevention

Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system for long-lasting HIV-prevention.

25 Mar 2017

Researchers propose new system to evaluate PrEP-based care for HIV prevention

One of the most promising new approaches to slowing the spread of HIV is pre-exposure prophylaxis (PrEP), a once-a-day medication that people who don't have HIV can take to prevent becoming infected.

15 Feb 2017

New antibody drug shows promising results to prevent or treat HIV

A new biologic agent--the most potent of its kind so far--is showing early promise as part of a potential new strategy for treating HIV. The drug, known as 10-1074, may also offer a new way to prevent viral infection in people who are at high risk to acquire HIV, the virus that causes AIDS.

7 Feb 2017